Tau phosphorylation and aggregation in Alzheimer's disease pathology

FEBS Letters

Volumn 580, Issue 12, 2006, Pages 2922-2927

  Avila, Jesús ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Aggregation; Alzheimer's disease; Phosphorylation; Tau; Tauopathies; Toxicity

Indexed keywords

AMYLOID BETA PROTEIN[25-35]; ARACHIDONIC ACID; GLYCOGEN SYNTHASE KINASE 3; HEPARIN; SERINE; TAU PROTEIN; THREONINE; UBIQUINONE; MAPT PROTEIN, HUMAN; MICROTUBULE ASSOCIATED PROTEIN;

ALZHEIMER DISEASE; CHROMOSOME 17; DEGENERATIVE DISEASE; DEMENTIA; GENE MUTATION; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PAIRED HELICAL FILAMENT; PARKINSONISM; PATHOLOGY; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN POLYMERIZATION; SHORT SURVEY; TAUOPATHY; HUMAN; METABOLISM; PHOSPHORYLATION; REVIEW;

ALZHEIMER DISEASE; GLYCOGEN SYNTHASE KINASE 3; HUMANS; MICROTUBULE-ASSOCIATED PROTEINS; PHOSPHORYLATION; TAU PROTEINS;

EID: 33745140951     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2006.02.067     Document Type: Short Survey

References (82)

1. Weingarten M.D., Lockwood A.H., Hwo S.Y., and Kirschner M.W. A protein factor essential for microtubule assembly. Proc. Natl. Acad. Sci. USA 72 (1975) 1858-1862
2. Caceres A., and Kosik K.S. Inhibition of neurite polarity by tau antisense oligonucleotides in primary cerebellar neurons. Nature 343 (1990) 461-463
3. Drubin D.G., and Kirschner M.W. Tau protein function in living cells. J. Cell. Biol. 103 (1986) 2739-2746
4. Ebneth A., Godemann R., Stamer K., Illenberger S., Trinczek B., Mandelkow E.M., and Mandelkow E. Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: implications for Alzheimer's disease. J. Cell. Biol. 143 (1998) 777-794
5. Stamer K., Vogel R., Thies E., Mandelkow E., and Mandelkow E.M. Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress. J. Cell. Biol. 156 (2002) 1051-1063
6. Trinczek B., Ebneth A., and Mandelkow E. Tau regulates the attachment/detachment but not the speed of motors in microtubule-dependent transport of single vesicles and organelles. J. Cell. Sci. 112 (1999) 2355-2367
7. Dawson H.N., Ferreira A., Eyster M.V., Ghoshal N., Binder L.I., and Vitek M.P. Inhibition of neuronal maturation in primary hippocampal neurons from tau deficient mice. J. Cell. Sci. 114 (2001) 1179-1187
8. Harada A., Oguchi K., Okabe S., Kuno J., Terada S., Ohshima T., Sato-Yoshitake R., Takei Y., Noda T., and Hirokawa N. Altered microtubule organization in small-calibre axons of mice lacking tau protein. Nature 369 (1994) 488-491
9. Grundke-Iqbal I., Iqbal K., Quinlan M., Tung Y.C., Zaidi M.S., and Wisniewski H.M. Microtubule-associated protein tau. A component of Alzheimer paired helical filaments. J. Biol. Chem. 261 (1986) 6084-6089
10. Alzheimer A. Ueber eigenartige Krankheitsfaelle des spaeteren Alters. Zeitschrift fuer die gesamte Neurologie und Psychiatrie 4 (1911) 356-386
11. Montejo de Garcini E., Serrano L., and Avila J. Self assembly of microtubule associated protein tau into filaments resembling those found in Alzheimer disease. Biochem. Biophys. Res. Commun. 141 (1986) 790-796
12. Goedert M., Wischik C.M., Crowther R.A., Walker J.E., and Klug A. Cloning and sequencing of the cDNA encoding a core protein of the paired helical filament of Alzheimer disease: identification as the microtubule-associated protein tau. Proc. Natl. Acad. Sci. USA 85 (1988) 4051-4055
13. Wischik C.M., Novak M., Thogersen H.C., Edwards P.C., Runswick M.J., Jakes R., Walker J.E., Milstein C., Roth M., and Klug A. Isolation of a fragment of tau derived from the core of the paired helical filament of Alzheimer disease. Proc. Natl. Acad. Sci. USA 85 (1988) 4506-4510
14. Grundke-Iqbal I., Iqbal K., Tung Y.C., Quinlan M., Wisniewski H.M., and Binder L.I. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc. Natl. Acad. Sci. USA 83 (1986) 4913-4917
15. Busciglio J., Lorenzo A., Yeh J., and Yankner B.A. Beta-amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron 14 (1995) 879-888
16. Himmler A. Structure of the bovine tau gene: alternatively spliced transcripts generate a protein family. Mol. Cell. Biol. 9 (1989) 1389-1396
17. Himmler A., Drechsel D., Kirschner M.W., and Martin D.J. Tau consists of a set of proteins with repeated C-terminal microtubule-binding domains and variable N-terminal domains. Mol. Cell. Biol. 9 (1989) 1381-1388
18. Goedert M. Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies. Philos. Trans. R. Soc. Lond. B Biol. Sci. 354 (1999) 1101-1118
19. Lee V.M., Goedert M., and Trojanowski J.Q. Neurodegenerative tauopathies. Annu. Rev. Neurosci. 24 (2001) 1121-1159
20. Goedert M., Spillantini M.G., Potier M.C., Ulrich J., and Crowther R.A. Cloning and sequencing of the cDNA encoding an isoform of microtubule-associated protein tau containing four tandem repeats: differential expression of tau protein mRNAs in human brain. EMBO J. 8 (1989) 393-399
21. Gong C.X., Liu F., Grundke-Iqbal I., and Iqbal K. Post-translational modifications of tau protein in Alzheimer's disease. J. Neural Transm. 112 (2005) 813-838
22. Morishima-Kawashima M., Hasegawa M., Takio K., Suzuki M., Yoshida H., Titani K., and Ihara Y. Proline-directed and non-proline-directed phosphorylation of PHF-tau. J. Biol. Chem. 270 (1995) 823-829
23. Goedert M., Hasegawa M., Jakes R., Lawler S., Cuenda A., and Cohen P. Phosphorylation of microtubule-associated protein tau by stress-activated protein kinases. FEBS Lett. 409 (1997) 57-62
24. Baudier J., Lee S.H., and Cole R.D. Separation of the different microtubule-associated tau protein species from bovine brain and their mode II phosphorylation by Ca2+/phospholipid-dependent protein kinase C. J. Biol. Chem. 262 (1987) 17584-17590
25. Correas I., Díaz-Nido J., and Avila J. Microtubule-associated protein tau is phosphorylated by protein kinase C on its tubulin binding domain. J. Biol. Chem. 267 (1992) 15721-15728
26. Drewes G., Lichtenberg K.B., Doring F., Mandelkow E.M., Biernat J., Goris J., Doree M., and Mandelkow E. Mitogen activated protein (MAP) kinase transforms tau protein into an Alzheimer-like state. EMBO J. 11 (1992) 2131-2138
27. Hanger D.P., Hughes K., Woodgett J.R., Brion J.P., and Anderton B.H. Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase. Neurosci. Lett. 147 (1992) 58-62
28. Imahori K., and Uchida T. Physiology and pathology of tau protein kinases in relation to Alzheimer's disease. J. Biochem. (Tokyo) 121 (1997) 179-188
29. Ishiguro K., Takamatsu M., Tomizawa K., Omori A., Takahashi M., Arioka M., Uchida T., and Imahori K. Tau protein kinase I converts normal tau protein into A68-like component of paired helical filaments. J. Biol. Chem. 267 (1992) 10897-10901
30. Lucas J.J., Hernandez F., Gomez-Ramos P., Moran M.A., Hen R., and Avila J. Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice. EMBO J. 20 (2001) 27-39
31. Scott C.W., Spreen R.C., Herman J.L., Chow F.P., Davison M.D., Young J., and Caputo C.B. Phosphorylation of recombinant tau by cAMP-dependent protein kinase. Identification of phosphorylation sites and effect on microtubule assembly. J. Biol. Chem. 268 (1993) 1166-1173
32. Perez M., Hernandez F., Lim F., Diaz-Nido J., and Avila J. Chronic lithium treatment decreases mutant tau protein aggregation in a transgenic mouse model. J. Alzheimers Dis. 5 (2003) 301-308
33. Noble W., Planel E., Zehr C., Olm V., Meyerson J., Suleman F., Gaynor K., Wang L., LaFrancois J., Feinstein B., Burns M., Krishnamurthy P., Wen Y., Bhat R., Lewis J., Dickson D., and Duff K. Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo. Proc. Natl. Acad. Sci. USA 102 (2005) 6990-6995
34. Brandt R., Hundelt M., and Shahani N. Tau alteration and neuronal degeneration in tauopathies: mechanisms and models. Biochim. Biophys. Acta 1739 (2005) 331-354
35. Johnson G.V., Jope R.S., and Binder L.I. Proteolysis of tau by calpain. Biochem. Biophys. Res. Commun. 163 (1989) 1505-1511
36. Shimura H., Schwartz D., Gygi S.P., and Kosik K.S. HIP-Hsc70 complex ubiquitinates phosphorylated tau and enhances cell survival. J. Biol. Chem. 279 (2004) 4869-4876
37. Price D.L., Sisodia S.S., and Borchelt D.R. Alzheimer disease - when and why?. Nat. Genet. 19 (1998) 314-316
38. Hardy J., and Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297 (2002) 353-356
39. Alvarez G., Muñoz-Montaño J.R., Satrústegui J., Avila J., Bogonez E., and Díaz-Nido J. Lithium protects cultured neurons against beta-amyloid-induced neurodegeneration. FEBS Lett. 453 (1999) 260-264
40. Baki L., Shioi J., Wen P., Shao Z., Schwarzman A., Gama-Sosa M., Neve R., and Robakis N.K. PS1 activates PI3K thus inhibiting GSK-3 activity and tau overphosphorylation: effects of FAD mutations. EMBO J. 23 (2004) 2586-2596
41. Weihl C.C., Ghadge G.D., Kennedy S.G., Hay N., Miller R.J., and Roos R.P. Mutant presenilin-1 induces apoptosis and downregulates Akt/PKB. J. Neurosci. 19 (1999) 5360-5369
42. Dermaut B., Kumar-Singh S., Engelborghs S., Theuns J., Rademakers R., Saerens J., Pickut B.A., Peeters K., van den Broeck M., Vennekens K., Claes S., Cruts M., Cras P., Martin J.J., Van Broeckhoven C., and De Deyn P.P. A novel presenilin 1 mutation associated with Pick's disease but not beta-amyloid plaques. Ann. Neurol. 55 (2004) 617-626
43. Wilhelmsen K.C., Lynch T., Pavlou E., Higgins M., and Nygaard T.G. Localization of disinhibition-dementia-parkinsonism-amyotrophy complex to 17q21-22. Am. J. Hum. Genet. 55 (1994) 1159-1165
44. Goedert M. Tau gene mutations and their effects. Mov. Disord. 20 Suppl 12 (2005) S45-S52
45. Goedert M., Satumtira S., Jakes R., Smith M.J., Kamibayashi C., White III C.L., and Sontag E. Reduced binding of protein phosphatase 2A to tau protein with frontotemporal dementia and parkinsonism linked to chromosome 17 mutations. J. Neurochem. 75 (2000) 2155-2162
46. Wille H., Drewes G., Biernat J., Mandelkow E.M., and Mandelkow E. Alzheimer-like paired helical filaments and antiparallel dimers formed from microtubule-associated protein tau in vitro. J. Cell. Biol. 118 (1992) 573-584
47. Crowther R.A., Olesen O.F., Jakes R., and Goedert M. The microtubule binding repeats of tau protein assemble into filaments like those found in Alzheimer's disease. FEBS Lett. 309 (1992) 199-202
48. Goedert M., Jakes R., Spillantini M.G., Hasegawa M., Smith M.J., and Crowther R.A. Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans. Nature 383 (1996) 550-553
49. Perez M., Valpuesta J.M., Medina M., Montejo de Garcini E., and Avila J. Polymerization of tau into filaments in the presence of heparin: the minimal sequence required for tau-tau interaction. J. Neurochem. 67 (1996) 1183-1190
50. Wilson D.M., and Binder L.I. Free fatty acids stimulate the polymerization of tau and amyloid beta peptides. In vitro evidence for a common effector of pathogenesis in Alzheimer's disease. Am. J. Pathol. 150 (1997) 2181-2195
51. Perez M., Cuadros R., Smith M.A., Perry G., and Avila J. Phosphorylated, but not native, tau protein assembles following reaction with the lipid peroxidation 4-hydroxy-2-nonenal. FEBS Lett. 486 (2000) 270-274
52. Santa-Maria I., Hernandez F., Martin C.P., Avila J., and Moreno F.J. Quinones facilitate the self-assembly of the phosphorylated tubulin binding region of tau into fibrillar polymers. Biochemistry 43 (2004) 2888-2897
53. von Bergen M., Friedhoff P., Biernat J., Heberle J., Mandelkow E.M., and Mandelkow E. Assembly of tau protein into Alzheimer paired helical filaments depends on a local sequence motif ((306)VQIVYK(311)) forming beta structure. Proc. Natl. Acad. Sci. USA 97 (2000) 5129-5134
54. Gamblin T.C. Potential structure/function relationships of predicted secondary structural elements of tau. Biochim. Biophys. Acta 1739 (2005) 140-149
55. Andorfer C., Acker C.M., Kress Y., Hof P.R., Duff K., and Davies P. Cell-cycle reentry and cell death in transgenic mice expressing nonmutant human tau isoforms. J. Neurosci. 25 (2005) 5446-5454
56. Lim F., Hernandez F., Lucas J.J., Gomez-Ramos P., Moran M.A., and Avila J. FTDP-17 mutations in tau transgenic mice provoke lysosomal abnormalities and Tau filaments in forebrain. Mol. Cell. Neurosci. 18 (2001) 702-714
57. Allen B., Ingram E., Takao M., Smith M.J., Jakes R., Virdee K., Yoshida H., Holzer M., Craxton M., Emson P.C., Atzori C., Migheli A., Crowther R.A., Ghetti B., Spillantini M.G., and Goedert M. Abundant tau filaments and nonapoptotic neurodegeneration in transgenic mice expressing human P301S tau protein. J. Neurosci. 22 (2002) 9340-9351
58. Takashima A., Noguchi K., Sato K., Hoshino T., and Imahori K. Tau protein kinase I is essential for amyloid beta-protein-induced neurotoxicity. Proc. Natl. Acad. Sci. USA 90 (1993) 7789-7793
59. Spillantini M.G., Murrell J.R., Goedert M., Farlow M.R., Klug A., and Ghetti B. Mutation in the tau gene in familial multiple system tauopathy with presenile dementia. Proc. Natl. Acad. Sci. USA 95 (1998) 7737-7741
60. Hutton M., Lendon C.L., Rizzu P., Baker M., Froelich S., Houlden H., Pickering-Brown S., Chakraverty S., Isaacs A., Grover A., Hackett J., Adamson J., Lincoln S., Dickson D., Davies P., Petersen R.C., Stevens M., de Graaff E., Wauters E., van Baren J., Hillebrand M., Joosse M., Kwon J.M., Nowotny P., Che L.K., Norton J., Morris J.C., Reed L.A., Trojanowski J., Basun H., Lannfelt L., Neystat M., Fahn S., Dark F., Tannenberg T., Dodd P.R., Hayward N., Kwok J.B., Schofield P.R., Andreadis A., Snowden J., Craufurd D., Neary D., Owen F., Oostra B.A., Hardy J., Goate A., van Swieten J., Mann D., Lynch T., and Heutink P. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393 (1998) 702-705
61. Poorkaj P., Bird T.D., Wijsman E., Nemens E., Garruto R.M., Anderson L., Andreadis A., Wiederholt W.C., Raskind M., and Schellenberg G.D. Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann. Neurol. 43 (1998) 815-825
62. Braak H., and Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. (Berl.) 82 (1991) 239-259
63. Delacourte A., David J.P., Sergeant N., Buee L., Wattez A., Vermersch P., Ghozali F., Fallet-Bianco C., Pasquier F., Lebert F., Petit H., and Di Menza C. The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease. Neurology 52 (1999) 1158-1165
64. Cras P., Smith M.A., Richey P.L., Siedlak S.L., Mulvihill P., and Perry G. Extracellular neurofibrillary tangles reflect neuronal loss and provide further evidence of extensive protein cross-linking in Alzheimer disease. Acta Neuropathol. (Berl.) 89 (1995) 291-295
65. Fukutani Y., Kobayashi K., Nakamura I., Watanabe K., Isaki K., and Cairns N.J. Neurons, intracellular and extracellular neurofibrillary tangles in subdivisions of the hippocampal cortex in normal ageing and Alzheimer's disease. Neurosci. Lett. 200 (1995) 57-60
66. Bondareff W., Mountjoy C.Q., Roth M., and Hauser D.L. Neurofibrillary degeneration and neuronal loss in Alzheimer's disease. Neurobiol. Aging 10 (1989) 709-715
67. Khlistunova I., Biernat J., Wang Y., Pickhardt M., von Bergen M., Gazova Z., Mandelkow E., and Mandelkow E.M. Inducible expression of Tau repeat domain in cell models of tauopathy: aggregation is toxic to cells but can be reversed by inhibitor drugs. J. Biol. Chem. 281 (2006) 1205-1214
68. Alonso A.D., Grundke-Iqbal I., Barra H.S., and Iqbal K. Abnormal phosphorylation of tau and the mechanism of Alzheimer neurofibrillary degeneration: sequestration of microtubule-associated proteins 1 and 2 and the disassembly of microtubules by the abnormal tau. Proc. Natl. Acad. Sci. USA 94 (1997) 298-303
69. Hernandez F., Perez M., Lucas J.J., and Avila J. Are intracellular paired helical filaments (PHFs) from Alzheimer's disease toxic for a neuron?. Brain Aging 1 (2001) 12-15
70. Iqbal K., Flory M., Khatoon S., Soininen H., Pirttila T., Lehtovirta M., Alafuzoff I., Blennow K., Andreasen N., Vanmechelen E., and Grundke-Iqbal I. Subgroups of Alzheimer's disease based on cerebrospinal fluid molecular markers. Ann. Neurol. 58 (2005) 748-757
71. Arrasate M., Mitra S., Schweitzer E.S., Segal M.R., and Finkbeiner S. Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature 431 (2004) 805-810
72. Lee H.G., Perry G., Moreira P.I., Garrett M.R., Liu Q., Zhu X., Takeda A., Nunomura A., and Smith M.A. Tau phosphorylation in Alzheimer's disease: pathogen or protector?. Trends Mol. Med. 11 (2005) 164-169
73. Santacruz K., Lewis J., Spires T., Paulson J., Kotilinek L., Ingelsson M., Guimaraes A., DeTure M., Ramsden M., McGowan E., Forster C., Yue M., Orne J., Janus C., Mariash A., Kuskowski M., Hyman B., Hutton M., and Ashe K.H. Tau suppression in a neurodegenerative mouse model improves memory function. Science 309 (2005) 476-481
74. Wittmann C.W., Wszolek M.F., Shulman J.M., Salvaterra P.M., Lewis J., Hutton M., and Feany M.B. Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles. Science 293 (2001) 711-714
75. Duff K., and Planel E. Untangling memory deficits. Nat. Med. 11 (2005) 826-827
76. Cleveland D.W., Hwo S.Y., and Kirschner M.W. Purification of tau, a microtubule-associated protein that induces assembly of microtubules from purified tubulin. J. Mol. Biol. 116 (1977) 207-225
77. Bird T.D., Nochlin D., Poorkaj P., Cherrier M., Kaye J., Payami H., Peskind E., Lampe T.H., Nemens E., Boyer P.J., and Schellenberg G.D. A clinical pathological comparison of three families with frontotemporal dementia and identical mutations in the tau gene (P301L). Brain 122 Pt 4 (1999) 741-756
78. Puig B., Ferrer I., Luduena R.F., and Avila J. BetaII-tubulin and phospho-tau aggregates in Alzheimer's disease and Pick's disease. J. Alzheimers Dis. 7 (2005) 213-220 discussion 255-262
79. Lazarov O., Peterson L.D., Peterson D.A., and Sisodia S.S. Expression of a familial Alzheimer's disease-linked presenilin-1 variant enhances perforant pathway lesion-induced neuronal loss in the entorhinal cortex. J. Neurosci. 26 (2006) 429-434
80. Santa-Maria I., Hernandez F., Smith M.A., Perry G., Avila J., and Moreno F.J. Neurotoxic dopamine quinone facilitates the assembly of tau into fibrillar polymers. Mol. Cell. Biochem. 278 (2005) 203-212
81. Arrasate M., Perez M., and Avila J. Tau dephosphorylation at tau-1 site correlates with its association to cell membrane. Neurochem. Res. 25 (2000) 43-50
82. Brandt R., Leger J., and Lee G. Interaction of tau with the neural plasma membrane mediated by tau's amino-terminal projection domain. J. Cell. Biol. 131 (1995) 1327-1340